Nel luglio 2024, uno studio pubblicato su JAMA Ophthalmology ha riportato che i pazienti trattati con semaglutide presentavano un rischio di perdita della vista sette volte superiore rispetto ai non utilizzatori
indicated that, in patients with T2DM, albiglutide did not increase adverse AF events and was instead associated with a trend toward reduced AF incidence during follow-up, although this relationship did not achieve statistical significance (135)
[DOI] [PubMed] [Google Scholar] 74.Alvarez J.A., Chowdhury R., Jones D.P., Martin G.S., Brigham K.L., Binongo J.N., Ziegler T.R., Tangpricha V
J.AdlerK
Bottom line: A small bruise at the injection site is usually a minor mechanical issue, not a sign of a drug allergy or a serious systemic problem
DOWNLOAD SDS